Elsevier Emergent Nanotherapeutics in Diabetic Complications

Emergent Nanotherapeutics in Diabetic Complications explores how cutting-edge nanotechnology is transforming the treatment of diabetes-related disorders beyond glycemic control. This comprehensive volume examines targeted, multifunctional nanoplatforms designed to address the wide range of comorbidities linked to diabetes, including vascular complications, metabolic dysfunctions, and impaired wound healing. Structured in five parts, the book spans from current nanoformulation strategies to emerging innovations such as CRISPR-Cas9 delivery, AI-guided nanoparticles, and 3D/4D printed nanostructures. Bridging the gap between preclinical research and clinical application, it offers valuable guidance on stimuli-responsive systems, biocompatible materials, and regulatory pathways. This is essential resource for medical professionals, biomedical engineers, and pharmaceutical scientists seeking scalable, next-generation solutions for managing diabetic complications through nanomedicine. Focuses on nanotherapeutics for diabetes-related complications, not just glucose control Covers nano-drug delivery systems for improved wound healing and comorbidity management Highlights next-generation technologies like CRISPR-Cas9, AI-driven nanoparticles, and 3D/4D nanostructures Includes guidance on translational research, clinical developments, and regulatory considerations